MENU
+Compare
PBH
Stock ticker: NYSE
AS OF
Dec 24 closing price
Price
$62.42
Change
+$0.11 (+0.18%)
Capitalization
3B

PBH Prestige Consumer Healthcare Forecast, Technical & Fundamental Analysis

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers... Show more

PBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PBH with price predictions
Dec 24, 2025

PBH in upward trend: price rose above 50-day moving average on December 12, 2025

PBH moved above its 50-day moving average on December 12, 2025 date and that indicates a change from a downward trend to an upward trend. In of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PBH's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 02, 2025. You may want to consider a long position or call options on PBH as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PBH just turned positive on November 26, 2025. Looking at past instances where PBH's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for PBH crossed bullishly above the 50-day moving average on December 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PBH advanced for three days, in of 340 cases, the price rose further within the following month. The odds of a continued upward trend are .

PBH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 267 cases where PBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PBH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.645) is normal, around the industry mean (24.311). P/E Ratio (15.450) is within average values for comparable stocks, (74.353). Projected Growth (PEG Ratio) (2.076) is also within normal values, averaging (1.954). PBH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.799) is also within normal values, averaging (64.216).

View a ticker or compare two or three
PBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PBH is expected to report earnings to rise 8.41% to $1.16 per share on February 05

Prestige Consumer Healthcare PBH Stock Earnings Reports
Q4'25
Est.
$1.16
Q3'25
Beat
by $0.10
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.30
Q4'24
Beat
by $0.06
The last earnings report on November 06 showed earnings per share of $1.07, beating the estimate of 97 cents. With 155.03K shares outstanding, the current market capitalization sits at 3.00B.
A.I. Advisor
published General Information

General Information

a company which markets over-the-counter drugs, household cleaning and personal care products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
660 White Plains Road
Phone
+1 914 524-6800
Employees
560
Web
https://www.prestigebrands.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSSGX16.840.08
+0.48%
Morgan Stanley Inst Inception I
MCRFX13.630.05
+0.37%
BlackRock Mid-Cap Value Investor C
ETTGX133.110.33
+0.25%
Eaton Vance Tx-Mgd Growth 1.1 A
TRLGX85.920.17
+0.20%
T. Rowe Price Lrg Cp Gr I
TSPTX5.440.01
+0.18%
Transamerica Small Cap Growth I3

PBH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.18%
PAHC - PBH
38%
Loosely correlated
+0.94%
IRWD - PBH
32%
Poorly correlated
+1.56%
AMRX - PBH
31%
Poorly correlated
+0.23%
ZTS - PBH
30%
Poorly correlated
+1.58%
ELAN - PBH
29%
Poorly correlated
+0.72%
More

Groups containing PBH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.18%
Pharmaceuticals: Generic
industry (212 stocks)
27%
Poorly correlated
+0.28%